Global Neural Stem Cells (NSCs) Market Professional Survey Report 2016
- QYR590929
- 109 Pages
- June 2016
- Pharmaceuticals
Product types including
Neural Crest Stem Cell(NC-SC)
CNS Stem Cells(CNS-SC)
The segment applications including
Neurodevelopmental
Repair damaged nerve tissue
Others
Segment regions including (the separated region report can also be offered)
North America
Europe
Japan
China
Southeast Asia
India
The players list (Partly, Players you are interested in can also be added)
3Dmatrix
Aldagen Inc.
Angioblast Systems
Arteriocyte
Athersys Inc.
Beike Biotechnology Co. Ltd.
Biotime Inc.
Brainstorm Cell Therapeutics Inc.
Caladrius Biosciences Inc.
Capricor Inc.
Cellerant Therapeutics Inc.
Cellerix Sa
Cellular Dynamics International
Celyad
Clontech
Cytori Therapeutics Inc.
Epistem Ltd.
Gamida Cell Ltd.
Globalstem
Hybrid Organ Gmbh
Intellicell Biosciences Inc.
International Stem Cell Corp.
Juventas Therapeutics Inc.
Mesoblast Ltd.
With 24 top producers.
Data including (both global and regions): Market Size (both volume - K MT and value - million USD), Market Share, Production data, Consumption data, Trade data, Price - USD/MT, Cost, Gross margin etc.
More detailed information, please refer to the attachment file and table of contents. If you have other requirements, please contact us, we can also offer!
1 Industry Overview of Neural Stem Cells (NSCs)
1.1 Definition and Specifications of Neural Stem Cells (NSCs)
1.1.1 Definition of Neural Stem Cells (NSCs)
1.1.2 Specifications of Neural Stem Cells (NSCs)
1.2 Classification of Neural Stem Cells (NSCs)
1.2.1 Neural Crest Stem Cell(NC-SC)
1.2.2 CNS Stem Cells(CNS-SC)
1.3 Applications of Neural Stem Cells (NSCs)
1.3.1 Neurodevelopmental
1.3.2 Repair damaged nerve tissue
1.3.3 Others
1.4 Industry Chain Structure of Neural Stem Cells (NSCs)
1.5 Industry Overview and Major Regions Status of Neural Stem Cells (NSCs)
1.5.1 Industry Overview of Neural Stem Cells (NSCs)
1.5.2 Global Major Regions Status of Neural Stem Cells (NSCs)
1.6 Industry Policy Analysis of Neural Stem Cells (NSCs)
1.7 Industry News Analysis of Neural Stem Cells (NSCs)
2 Manufacturing Cost Structure Analysis of Neural Stem Cells (NSCs)
2.1 Raw Material Suppliers and Price Analysis of Neural Stem Cells (NSCs)
2.2 Equipment Suppliers and Price Analysis of Neural Stem Cells (NSCs)
2.3 Labor Cost Analysis of Neural Stem Cells (NSCs)
2.4 Other Costs Analysis of Neural Stem Cells (NSCs)
2.5 Manufacturing Cost Structure Analysis of Neural Stem Cells (NSCs)
2.6 Manufacturing Process Analysis of Neural Stem Cells (NSCs)
3 Technical Data and Manufacturing Plants Analysis of Neural Stem Cells (NSCs)
3.1 Capacity and Commercial Production Date of Global Neural Stem Cells (NSCs) Major Manufacturers in 2015
3.2 Manufacturing Plants Distribution of Global Neural Stem Cells (NSCs) Major Manufacturers in 2015
3.3 R&D Status and Technology Source of Global Neural Stem Cells (NSCs) Major Manufacturers in 2015
3.4 Raw Materials Sources Analysis of Global Neural Stem Cells (NSCs) Major Manufacturers in 2015
4 Global Neural Stem Cells (NSCs) Overall Market Overview
4.1 2011-2016E Overall Market Analysis
4.2.1 2011-2015 Global Neural Stem Cells (NSCs) Capacity and Growth Rate Analysis
4.2.2 2015 Neural Stem Cells (NSCs) Capacity Analysis (Company Segment)
4.3 Sales Analysis
4.3.1 2011-2015 Global Neural Stem Cells (NSCs) Sales and Growth Rate Analysis
4.3.2 2015 Neural Stem Cells (NSCs) Sales Analysis (Company Segment)
4.4 Sales Price Analysis
4.4.1 2011-2015 Global Neural Stem Cells (NSCs) Sales Price
4.4.2 2015 Neural Stem Cells (NSCs) Sales Price Analysis (Company Segment)
4.5 Gross Margin Analysis
4.5.1 2011-2015 Global Neural Stem Cells (NSCs) Gross Margin
4.5.2 2015 Neural Stem Cells (NSCs) Gross Margin Analysis (Company Segment)
5 Neural Stem Cells (NSCs) Regional Market Analysis
5.1 North America Neural Stem Cells (NSCs) Market Analysis
5.1.1 North America Neural Stem Cells (NSCs) Market Overview
5.1.2 North America 2011-2016E Neural Stem Cells (NSCs) Local Supply, Import, Export, Local Consumption Analysis
5.1.3 North America 2011-2016E Neural Stem Cells (NSCs) Sales Price Analysis
5.1.4 North America 2015 Neural Stem Cells (NSCs) Market Share Analysis
5.2 Europe Neural Stem Cells (NSCs) Market Analysis
5.2.1 Europe Neural Stem Cells (NSCs) Market Overview
5.2.2 Europe 2011-2016E Neural Stem Cells (NSCs) Local Supply, Import, Export, Local Consumption Analysis
5.2.3 Europe 2011-2016E Neural Stem Cells (NSCs) Sales Price Analysis
5.2.4 Europe 2015 Neural Stem Cells (NSCs) Market Share Analysis
5.3 Japan Neural Stem Cells (NSCs) Market Analysis
5.3.1 Japan Neural Stem Cells (NSCs) Market Overview
5.3.2 Japan 2011-2016E Neural Stem Cells (NSCs) Local Supply, Import, Export, Local Consumption Analysis
5.3.3 Japan 2011-2016E Neural Stem Cells (NSCs) Sales Price Analysis
5.3.4 Japan 2015 Neural Stem Cells (NSCs) Market Share Analysis
5.4 China Neural Stem Cells (NSCs) Market Analysis
5.4.1 China Neural Stem Cells (NSCs) Market Overview
5.4.2 China 2011-2016E Neural Stem Cells (NSCs) Local Supply, Import, Export, Local Consumption Analysis
5.4.3 China 2011-2016E Neural Stem Cells (NSCs) Sales Price Analysis
5.4.4 China 2015 Neural Stem Cells (NSCs) Market Share Analysis
5.5 Southeast Asia Neural Stem Cells (NSCs) Market Analysis
5.5.1 Southeast Asia Neural Stem Cells (NSCs) Market Overview
5.5.2 Southeast Asia 2011-2016E Neural Stem Cells (NSCs) Local Supply, Import, Export, Local Consumption Analysis
5.5.3 Southeast Asia 2011-2016E Neural Stem Cells (NSCs) Sales Price Analysis
5.5.4 Southeast Asia 2015 Neural Stem Cells (NSCs) Market Share Analysis
5.6 India Neural Stem Cells (NSCs) Market Analysis
5.6.1 India Neural Stem Cells (NSCs) Market Overview
5.6.2 India 2011-2016E Neural Stem Cells (NSCs) Local Supply, Import, Export, Local Consumption Analysis
5.6.3 India 2011-2016E Neural Stem Cells (NSCs) Sales Price Analysis
5.6.4 India 2015 Neural Stem Cells (NSCs) Market Share Analysis
6 Global 2011-2016E Neural Stem Cells (NSCs) Segment Market Analysis (by Type)
6.1 Global 2011-2016E Neural Stem Cells (NSCs) Sales by Type
6.2 Different Types Neural Stem Cells (NSCs) Product Interview Price Analysis
6.3 Different Types Neural Stem Cells (NSCs) Product Driving Factors Analysis
6.3.1 Neural Crest Stem Cell(NC-SC) Neural Stem Cells (NSCs) Growth Driving Factor Analysis
6.3.2 CNS Stem Cells(CNS-SC) Neural Stem Cells (NSCs) Growth Driving Factor Analysis
7 Global 2011-2016E Neural Stem Cells (NSCs) Segment Market Analysis (by Application)
7.1 Global 2011-2016E Consumption by Application
7.2 Different Application Product Interview Price Analysis
7.3 Different Application Product Driving Factors Analysis
7.3.1 Neurodevelopmental Neural Stem Cells (NSCs) Growth Driving Factor Analysis
7.3.2 Repair damaged nerve tissue Neural Stem Cells (NSCs) Growth Driving Factor Analysis
7.3.3 Others Neural Stem Cells (NSCs) Growth Driving Factor Analysis
8 Major Manufacturers Analysis of Neural Stem Cells (NSCs)
8.1 3Dmatrix
8.1.1 Company Profile
8.1.2 Product Picture and Specifications
8.1.3 3Dmatrix 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.1.4 3Dmatrix 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.2 Aldagen Inc.
8.2.1 Company Profile
8.2.2 Product Picture and Specifications
8.2.3 Aldagen Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.2.4 Aldagen Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.3 Angioblast Systems
8.3.1 Company Profile
8.3.2 Product Picture and Specifications
8.3.3 Angioblast Systems 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.3.4 Angioblast Systems 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.4 Arteriocyte
8.4.1 Company Profile
8.4.2 Product Picture and Specifications
8.4.3 Arteriocyte 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.4.4 Arteriocyte 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.5 Athersys Inc.
8.5.1 Company Profile
8.5.2 Product Picture and Specifications
8.5.3 Athersys Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.5.4 Athersys Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.6 Beike Biotechnology Co. Ltd.
8.6.1 Company Profile
8.6.2 Product Picture and Specifications
8.6.3 Beike Biotechnology Co. Ltd. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.6.4 Beike Biotechnology Co. Ltd. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.7 Biotime Inc.
8.7.1 Company Profile
8.7.2 Product Picture and Specifications
8.7.3 Biotime Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.7.4 Biotime Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.8 Brainstorm Cell Therapeutics Inc.
8.8.1 Company Profile
8.8.2 Product Picture and Specifications
8.8.3 Brainstorm Cell Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.8.4 Brainstorm Cell Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.9 Caladrius Biosciences Inc.
8.9.1 Company Profile
8.9.2 Product Picture and Specifications
8.9.3 Caladrius Biosciences Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.9.4 Caladrius Biosciences Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.10 Capricor Inc.
8.10.1 Company Profile
8.10.2 Product Picture and Specifications
8.10.3 Capricor Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.10.4 Capricor Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.11 Cellerant Therapeutics Inc.
8.11.1 Company Profile
8.11.2 Product Picture and Specifications
8.11.3 Cellerant Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.11.4 Cellerant Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.12 Cellerix Sa
8.12.1 Company Profile
8.12.2 Product Picture and Specifications
8.12.3 Cellerix Sa 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.12.4 Cellerix Sa 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.13 Cellular Dynamics International
8.13.1 Company Profile
8.13.2 Product Picture and Specifications
8.13.3 Cellular Dynamics International 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.13.4 Cellular Dynamics International 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.14 Celyad
8.14.1 Company Profile
8.14.2 Product Picture and Specifications
8.14.3 Celyad 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.14.4 Celyad 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.15 Clontech
8.15.1 Company Profile
8.15.2 Product Picture and Specifications
8.15.3 Clontech 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.15.4 Clontech 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.16 Cytori Therapeutics Inc.
8.16.1 Company Profile
8.16.2 Product Picture and Specifications
8.16.3 Cytori Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.16.4 Cytori Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.17 Epistem Ltd.
8.17.1 Company Profile
8.17.2 Product Picture and Specifications
8.17.3 Epistem Ltd. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.17.4 Epistem Ltd. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.18 Gamida Cell Ltd.
8.18.1 Company Profile
8.18.2 Product Picture and Specifications
8.18.3 Gamida Cell Ltd. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.18.4 Gamida Cell Ltd. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.19 Globalstem
8.19.1 Company Profile
8.19.2 Product Picture and Specifications
8.19.3 Globalstem 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.19.4 Globalstem 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.20 Hybrid Organ Gmbh
8.20.1 Company Profile
8.20.2 Product Picture and Specifications
8.20.3 Hybrid Organ Gmbh 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.20.4 Hybrid Organ Gmbh 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.21 Intellicell Biosciences Inc.
8.21.1 Company Profile
8.21.2 Product Picture and Specifications
8.21.3 Intellicell Biosciences Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.21.4 Intellicell Biosciences Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.22 International Stem Cell Corp.
8.22.1 Company Profile
8.22.2 Product Picture and Specifications
8.22.3 International Stem Cell Corp. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.22.4 International Stem Cell Corp. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.23 Juventas Therapeutics Inc.
8.23.1 Company Profile
8.23.2 Product Picture and Specifications
8.23.3 Juventas Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.23.4 Juventas Therapeutics Inc. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
8.24 Mesoblast Ltd.
8.24.1 Company Profile
8.24.2 Product Picture and Specifications
8.24.3 Mesoblast Ltd. 2015 Neural Stem Cells (NSCs) Sales, Ex-factory Price, Revenue, Gross Margin Analysis
8.24.4 Mesoblast Ltd. 2015 Neural Stem Cells (NSCs) Business Region Distribution Analysis
9 Development Trend of Analysis of Market
9.1 Global Market Trend Analysis
9.1.1 Global 2016-2021 Market Size (Volume and Value) Forecast
9.1.2 Global 2016-2021 Sales Price Forecast
9.1.3 Global 2016-2021 Gross Margin Forecast
9.2 Regional Market Trend
9.2.1 North America 2016-2021 Neural Stem Cells (NSCs) Consumption Forecast
9.2.2 Europe 2016-2021 Neural Stem Cells (NSCs) Consumption Forecast
9.2.3 Japan 2016-2021 Neural Stem Cells (NSCs) Consumption Forecast
9.2.4 China 2016-2021 Neural Stem Cells (NSCs) Consumption Forecast
9.2.5 Southeast Asia 2016-2021 Neural Stem Cells (NSCs) Consumption Forecast
9.2.6 India 2016-2021 Neural Stem Cells (NSCs) Consumption Forecast
9.3 Market Trend (Product type)
9.4 Market Trend (Application)
10 Neural Stem Cells (NSCs) Marketing Model Analysis
10.1 Neural Stem Cells (NSCs) Regional Marketing Model Analysis
10.2 Neural Stem Cells (NSCs) International Trade Model Analysis
10.3 Traders or Distributors with Contact Information of Neural Stem Cells (NSCs) by Regions
10.4 Neural Stem Cells (NSCs) Supply Chain Analysis
11 Consumers Analysis of Neural Stem Cells (NSCs)
11.1 Consumer 1 Analysis
11.2 Consumer 2 Analysis
11.3 Consumer 3 Analysis
11.4 Consumer 4 Analysis
…
12 New Project Investment Feasibility Analysis of Neural Stem Cells (NSCs)
12.1 New Project SWOT Analysis of Neural Stem Cells (NSCs)
12.2 New Project Investment Feasibility Analysis of Neural Stem Cells (NSCs)
13 Conclusion of the Global Neural Stem Cells (NSCs) Market Professional Survey Report 2016
N/A
Similar Reports
Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...
- Publish Date: November 14, 2017
- $5370
Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...
- Publish Date: July 20, 2017
- $5370
The pharmaceutical agents that are administered to treat, diagnose, and prevent life-threatening diseases (rare diseases) are known as orphan drugs. The global orphan drugs market accounted for $106 billion in 2015, and is anticipated to reach $169 billio...
- Publish Date: April 24, 2017
- $5370
